⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10005833 | 1.00 | — | — | |
| SCHEMBL16674740 | 0.89 | INPP5A (0.34) | — | |
| SCHEMBL16674741 | 0.88 | — | — | |
| SCHEMBL15806353 | 0.88 | — | — | |
| SCHEMBL15788841 | 0.87 | — | — | |
| SCHEMBL15905936 | 0.87 | — | — | |
| SCHEMBL24778339 | 0.86 | — | — | |
| SCHEMBL2755679 | 0.86 | — | — | |
| SCHEMBL10032931 | 0.86 | — | — | |
| SCHEMBL1644540 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11702652-B2 | Enzymatic encoding methods for efficient synthesis of large libraries | NUEVOLUTION A/S (DK) | 2023-07-18 | — | — | US | disclosed |
| US-20230167502-A1 | DIAGNOSTIC METHODS USING MIR-485-3P EXPRESSION | BIORCHESTRA CO., LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20180112217-A1 | Stereospecific Phosphorothioate LNA | ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) | 2018-04-26 | — | — | US | disclosed |
| US-9885035-B2 | Method for the synthesis of a bifunctional complex | NUEVOLUTION A/S (DK) | 2018-02-06 | — | — | US | disclosed |
| US-20170247688-A1 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION A/S (DK) | 2017-08-31 | — | — | US | disclosed |
| US-9738894-B2 | Short interfering RNA (siRNA) analogues | ROCHE INNOVATION CENTER COPENHAGEN A/S (CH) | 2017-08-22 | — | — | US | disclosed |
| US-9574189-B2 | Enzymatic encoding methods for efficient synthesis of large libraries | NUEVOLUTION A/S (DK) | 2017-02-21 | — | — | US | disclosed |
| US-20170009225-A1 | METHOD FOR THE SYNTHESIS OF A BIFUNCTIONAL COMPLEX | NUEVOLUTION A/S (DK) | 2017-01-12 | — | — | US | disclosed |
| US-20170009237-A1 | Short Interfering RNA (siRNA) Analogues | SANTARIS PHARMA A/S (DK) | 2017-01-12 | — | — | US | disclosed |
| US-9487775-B2 | Method for the synthesis of a bifunctional complex | NUEVOLUTION A/S (DK) | 2016-11-08 | — | — | US | disclosed |
| US-20110224285-A1 | OLIGOMERIC COMPOUNDS FOR THE MODULATION OF HIF-1A EXPRESSION | ENZON PHARMACEUTICALS, INC. (US) | 2011-09-15 | — | — | US | disclosed |
| US-7915201-B2 | Ligational encoding of small molecules | NUEVOLUTION A/S (DK) | 2011-03-29 | — | — | US | disclosed |
| US-20100286290-A1 | ENZYME ACTIVITY ASSAY USING ROLLING CIRCLE AMPLIFICATION | IN SITU RCP A/S (DK) | 2010-11-11 | — | — | US | disclosed |
| US-7737125-B2 | LNA antagonists targeting the androgen receptor | ENZON PHARAMACEUTICALS, INC. (US) | 2010-06-15 | — | — | US | disclosed |
| US-20090264300-A1 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION A/S (DK) | 2009-10-22 | — | — | US | disclosed |
| US-20090239211-A1 | Method For Enrichment Involving Elimination By Mismatch Hybridisation | NUEVOLUTION A/S (DK) | 2009-09-24 | — | — | US | disclosed |
| US-20090181916-A1 | LNA ANTAGONISTS TARGETING THE ANDROGEN RECEPTOR | SANTARIS PHARMA A/S (DK) | 2009-07-16 | — | — | US | disclosed |
| US-20090143232-A1 | METHOD FOR SYNTHESISING TEMPLATED MOLECULES | NUEVOLUTION A/S (DK) | 2009-06-04 | — | — | US | disclosed |
| US-7413854-B2 | Method for synthesising templated molecules | NUEVOLUTION A/S (DK) | 2008-08-19 | — | — | US | disclosed |
| US-20070026397-A1 | Method for producing second-generation library | NUEVOLUTION A/S (DK) | 2007-02-01 | — | — | US | disclosed |